Extra-articular manifestations of ankylosing spondylitis: Prevalence, characteristics and therapeutic implications

European Journal of Internal Medicine

Volumn 22, Issue 6, 2011, Pages 554-560

  El Maghraoui, Abdellah ^a  

^a MILITARY HOSPITAL MOHAMMED V   (Morocco)

Author keywords

Ankylosing spondylitis; Extra articular manifestation; Inflammatory bowel disease; Lung; Osteoporosis; Uveitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CELECOXIB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PLACEBO; PREDNISOLONE ACETATE; SALAZOSULFAPYRIDINE; SCOPOLAMINE;

ANKYLOSING SPONDYLITIS; AORTA VALVE REGURGITATION; ATRIOVENTRICULAR BLOCK; BONE DENSITY; BRONCHIECTASIS; CARDIOVASCULAR RISK; CROHN DISEASE; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; GLOMERULONEPHRITIS; HEART BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEMATURIA; HOLTER MONITORING; HUMAN; HYPERTENSION; INTERSTITIAL LUNG DISEASE; IRIDOCYCLITIS; KIDNEY AMYLOIDOSIS; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; META ANALYSIS (TOPIC); MICROALBUMINURIA; OSTEOPOROSIS; PHYSIOTHERAPY; PREVALENCE; PSORIASIS; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REACTIVE ARTHRITIS; REVIEW; RHEUMATOLOGY; SACROILIITIS; THORAX RADIOGRAPHY; ULCERATIVE COLITIS; UVEITIS; VALVULAR HEART DISEASE; VERTEBRA FRACTURE;

EID: 80855131442     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.06.006     Document Type: Short Survey

References (68)

1. J. Sieper, J. Braun, M. Rudwaleit, A. Boonen, and A. Zink Ankylosing spondylitis: an overview Ann Rheum Dis 61 Suppl. 3 2002 iii8 iii18
2. A. El Maghraoui Ankylosing spondylitis Presse Med 33 2004 1459 1464 (Pubitemid 39587029)
3. D. Elewaut, and M. Matucci-Cerinic Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice Rheumatology (Oxford) 48 2009 1029 1035
4. S. Munoz-Fernandez, and E. Martin-Mola Uveitis Best Pract Res Clin Rheumatol 20 2006 487 505 (Pubitemid 43843070)
5. N. Zeboulon, M. Dougados, and L. Gossec Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review Ann Rheum Dis 67 2008 955 959 (Pubitemid 351956657)
6. S. Munoz-Fernandez, V. Hidalgo, J. Fernandez-Melon, A. Schlincker, G. Bonilla, and D. Ruiz-Sancho Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period J Rheumatol 30 2003 1277 1279 (Pubitemid 36666354)
7. J.M. Benitez-Del-Castillo, J. Garcia-Sanchez, T. Iradier, and A. Banares Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis Eye 14 Pt 3A 2000 340 343 (Pubitemid 30479708)
8. M. Dougados, F. Berenbaum, A. Maetzel, and B. Amor Prevention of acute anterior uveitis associated with spondylarthropathy induced by salazosulfapyridine Rev Rhum Ed Fr 60 1993 81 83
9. G. Levy-Clarke, and R. Nussenblatt Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis? Nat Clin Pract Rheumatol 2 2006 72 73 (Pubitemid 43239205)
10. J. Braun, X. Baraliakos, J. Listing, and J. Sieper Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept Arthritis Rheum 52 2005 2447 2451 (Pubitemid 41117431)
11. S. Guignard, L. Gossec, C. Salliot, A. Ruyssen-Witrand, M. Luc, and M. Duclos Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study Ann Rheum Dis 65 2006 1631 1634 (Pubitemid 44799677)
12. J. Sieper, A.S. Koenig, S. Baumgartner, C. Wishneski, J. Foehl, and B. Vlahos Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials Ann Rheum Dis 69 2010 226 229
13. M. Rudwaleit, E. Rodevand, P. Holck, J. Vanhoof, M. Kron, and S. Kary Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study Ann Rheum Dis 68 2009 696 701
14. F. De Keyser, and H. Mielants The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface J Rheumatol 30 2003 2306 2307 (Pubitemid 37413883)
15. M. Rudwaleit, and D. Baeten Ankylosing spondylitis and bowel disease Best Pract Res Clin Rheumatol 20 2006 451 471 (Pubitemid 43843072)
16. J. Zochling, D. van der Heijde, R. Burgos-Vargas, E. Collantes, J.C. Davis Jr., and B. Dijkmans ASAS/EULAR recommendations for the management of ankylosing spondylitis Ann Rheum Dis 65 2006 442 452
17. J. Braun, J. Davis, M. Dougados, J. Sieper, S. van der Linden, and D. van der Heijde First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis Ann Rheum Dis 65 2006 316 320 (Pubitemid 43268219)
18. I.H. Song, H. Appel, H. Haibel, C. Loddenkemper, J. Braun, and J. Sieper New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept J Rheumatol 35 2008 532 536 (Pubitemid 351374434)
19. J. Braun, X. Baraliakos, J. Listing, J. Davis, D. van der Heijde, and H. Haibel Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents Arthritis Rheum 57 2007 639 647 (Pubitemid 46764055)
20. D. Tracey, L. Klareskog, E.H. Sasso, J.G. Salfeld, and P.P. Tak Tumor necrosis factor antagonist mechanisms of action: a comprehensive review Pharmacol Ther 117 2008 244 279
21. Z. Kaymakcalan, P. Sakorafas, S. Bose, S. Scesney, L. Xiong, and D.K. Hanzatian Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor Clin Immunol 131 2009 308 316
22. P. Goupille Psoriatic arthritis Joint Bone Spine 72 2005 466 470 (Pubitemid 41821400)
23. F. Lavie, C. Salliot, E. Dernis, P. Claudepierre, T. Schaeverbeke, and J. Tebib Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: Development of recommendations for clinical practice based on published evidence and expert opinion Joint Bone Spine 76 2009 540 546
24. S.M. Hoy, and L.J. Scott Etanercept: a review of its use in the management of ankylosing spondylitis and psoriatic arthritis Drugs 67 2007 2609 2633 (Pubitemid 350159169)
25. L. Barra, J.E. Pope, and M. Payne Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire J Rheumatol 36 2009 1421 1428
26. V. Brodszky, M. Pentek, and L. Gulacsi Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment Scand J Rheumatol 37 2008 399 400
27. D.D. Gladman Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis Nat Clin Pract Rheumatol 4 2008 510 511
28. D. Wendling, J.C. Balblanc, D. Briancon, A. Brousse, A. Lohse, and P. Deprez Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapy Joint Bone Spine 75 2008 315 318
29. K. Karberg, J. Zochling, J. Sieper, D. Felsenberg, and J. Braun Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes J Rheumatol 32 2005 1290 1298 (Pubitemid 40995385)
30. P. Geusens, D. Vosse, and S. van der Linden Osteoporosis and vertebral fractures in ankylosing spondylitis Curr Opin Rheumatol 19 2007 335 339 (Pubitemid 46884187)
31. A. El Maghraoui Osteoporosis and ankylosing spondylitis Joint Bone Spine 71 2004 291 295 (Pubitemid 39037316)
32. A. El Maghraoui, D. Borderie, B. Cherruau, R. Edouard, M. Dougados, and C. Roux Osteoporosis, body composition, and bone turnover in ankylosing spondylitis J Rheumatol 26 1999 2205 2209 (Pubitemid 29487018)
33. A. El Maghraoui, S. Tellal, S. Chaouir, K. Lebbar, A. Bezza, and A. Nouijai Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis Clin Rheumatol 24 2005 346 351 (Pubitemid 41102431)
34. A. El Maghraoui, and C. Roux DXA scanning in clinical practice QJM 101 2008 605 617
35. J.F. Maillefert, L.S. Aho, A. El Maghraoui, M. Dougados, and C. Roux Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study Osteoporos Int 12 2001 605 609 (Pubitemid 32777439)
36. J. Gratacos, A. Collado, F. Pons, M. Osaba, R. Sanmarti, and M. Roque Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study Arthritis Rheum 42 1999 2319 2324 (Pubitemid 30333411)
37. C. Cooper, L. Carbone, C.J. Michet, E.J. Atkinson, W.M. O'Fallon, and L.J. Melton III Fracture risk in patients with ankylosing spondylitis: a population based study J Rheumatol 21 1994 1877 1882 (Pubitemid 24312651)
38. S.H. Ralston, G.D. Urquhart, M. Brzeski, and R.D. Sturrock Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis BMJ 300 1990 563 565 (Pubitemid 20090269)
39. I. Ghozlani, M. Ghazi, A. Nouijai, A. Mounach, A. Rezqi, and L. Achemlal Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis Bone 44 2009 772 776
40. D. Vosse, R. Landewe, D. van der Heijde, S. van der Linden, T.P. van Staa, and P. Geusens Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case control study Ann Rheum Dis 68 2009 1839 1842
41. D. Vosse, D. van der Heijde, R. Landewe, P. Geusens, H. Mielants, and M. Dougados Determinants of hyperkyphosis in patients with ankylosing spondylitis Ann Rheum Dis 65 2006 770 774 (Pubitemid 43803770)
42. D. Vosse, E. Feldtkeller, J. Erlendsson, P. Geusens, and S. van der Linden Clinical vertebral fractures in patients with ankylosing spondylitis J Rheumatol 31 2004 1981 1985 (Pubitemid 39336723)
43. K. Briot, L. Gossec, S. Kolta, M. Dougados, and C. Roux Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment J Rheumatol 35 2008 855 861 (Pubitemid 351747128)
44. C.A. Roldan Valvular and coronary heart disease in systemic inflammatory diseases: systemic disorders in heart disease Heart 94 2008 1089 1101 (Pubitemid 352039899)
45. F. Brunner, A. Kunz, U. Weber, and R. Kissling Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol 25 2006 24 29
46. T.W. O'Neill, and B. Bresnihan The heart in ankylosing spondylitis Ann Rheum Dis 51 1992 705 706
47. K. Lehtinen Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis Ann Rheum Dis 52 1993 174 176 (Pubitemid 23094303)
48. D. Lautermann, and J. Braun Ankylosing spondylitis-cardiac manifestations Clin Exp Rheumatol 20 2002 S11 S15
49. M.J. Peters, I. Visman, M.M. Nielen, N. van Dillen, R.A. Verheij, and IE. van der Horst-Bruinsma Ankylosing spondylitis; a risk factor for myocardial infarction? Ann Rheum Dis 69 2010 579 581
50. I. Sari, T. Okan, S. Akar, H. Cece, C. Altay, and M. Secil Impaired endothelial function in patients with ankylosing spondylitis Rheumatology (Oxford) 45 2006 283 286 (Pubitemid 43372841)
51. M. Caliskan, D. Erdogan, H. Gullu, S. Yilmaz, Y. Gursoy, and A. Yildirir Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis Atherosclerosis 196 2008 306 312
52. I.C. van Eijk, M.K. de Vries, J.H. Levels, M.J. Peters, E.E. Huizer, and B.A. Dijkmans Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis Arthritis Rheum 60 2009 1324 1330
53. M.J. Peters, I.E. van der Horst-Bruinsma, B.A. Dijkmans, and M.T. Nurmohamed Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis Semin Arthritis Rheum 34 2004 585 592 (Pubitemid 39643120)
54. W.W. Bolten Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs Ann Rheum Dis 65 2006 7 13 (Pubitemid 41815632)
55. A. Wanders, D. Heijde, R. Landewe, J.M. Behier, A. Calin, and I. Olivieri Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial Arthritis Rheum 52 2005 1756 1765 (Pubitemid 40852884)
56. L.M. Fischer, R.G. Schlienger, C.M. Matter, H. Jick, and C.R. Meier Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction Arch Intern Med 164 2004 2472 2476 (Pubitemid 39628075)
57. N. Akkoc, S. van der Linden, and M.A. Khan Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy Best Pract Res Clin Rheumatol 20 2006 539 557 (Pubitemid 43843066)
58. A. El Maghraoui Pleuropulmonary involvement in ankylosing spondylitis Joint Bone Spine 72 2005 496 502 (Pubitemid 41821407)
59. A. El-Maghraoui, S. Chaouir, A. Bezza, F. Tabache, A. Abouzahir, and D. Ghafir Thoracic high resolution computed tomography in patients with ankylosing spondylitis and without respiratory symptoms Ann Rheum Dis 62 2003 185 186 (Pubitemid 36135400)
60. A. El Maghraoui, S. Chaouir, A. Abid, A. Bezza, F. Tabache, and L. Achemlal Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin Rheumatol 23 2004 123 128 (Pubitemid 38559182)
61. A.J. Ostor, A.J. Crisp, M.F. Somerville, and D.G. Scott Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab BMJ 329 2004 1266 (Pubitemid 39576730)
62. A. Nouijai, A. Mounach, I. Ghozlani, L. Achemlal, and A. Bezza El Maghraoui A Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab. Presse Med 38 2009 17 20
63. E. Bargagli, M. Galeazzi, and P. Rottoli Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis Eur Respir J 24 2004 708 (Pubitemid 39406147)
64. J. Ledingham, C. Wilkinson, and C. Deighton British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-{alpha} treatments Rheumatology (Oxford) 44 2005 1205 1206 (Pubitemid 41487949)
65. G. Singh, N. Kumari, A. Aggarwal, N. Krishnani, and R. Misra Prevalence of subclinical amyloidosis in ankylosing spondylitis J Rheumatol 34 2007 371 373
66. J. Gratacos, C. Orellana, R. Sanmarti, M. Sole, A. Collado, and E. Gomez-Casanovas Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration J Rheumatol 24 1997 912 915 (Pubitemid 27223627)
67. S. Kobak, F. Oksel, Y. Kabasakal, and E. Doganavsargil Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients Clin Rheumatol 26 2007 2191 2194 (Pubitemid 350120369)
68. J. Braun, T. Pham, J. Sieper, J. Davis, S. van der Linden, and M. Dougados International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis Ann Rheum Dis 62 2003 817 824 (Pubitemid 37026490)